Good Growth Capital
SlowingFiled to raiseCharleston, SCBiotech & pharma, Digital health, Medical devicesLast fund filed May 2026
6 on a current fund
last 24 months
across filed funds
| Vehicle | Filed | Target | Sold to date | Investors |
|---|---|---|---|---|
| Good Life Sciences Generations Fund I | May 2026 | Indefinite | $1.5M | 3 |
| Good Growth Capital Fund III | May 2023 | $250M | $43M | 75 |
| Good Growth Capital Fund IIFiled to raise in 2020, with no closing reported yet. | 2020 | $100M | $0 | 0 |
Amounts are Item 13 as filed: the target is the whole offering, and the amount sold is cumulative across amendments rather than a final close. The filing carries no per-investor amount, so a firm’s own cheque is not recoverable here.
9 partners are named across this firm’s filings, 6 of them on a fund it is deploying now.
| Partner | Activity | Categories | Board seats | Last 24mo |
|---|---|---|---|---|
| David Mendez | Slowing | None listed | 2 | 1 |
Categories of Good Growth Capital’s own portfolio companies, based on 4 with a verified or cited source.
Not a filing value: this is Lev’s own classification of each company, one company one vote regardless of how many of Good Growth Capital’s partners are named on its board, shown only when we found a specific, checkable source. Companies with no source read as unclassified and are left out of the shares above.
| Firm | Shared boards | Companies |
|---|---|---|
| Baird Venture Partners | 1 | CRAYON |
| Founder Collective | 1 | CRAYON |
| Harbert Growth Partners | 1 | Pleural Dynamics |
| Polaris Partners | 1 |
| Amy Salzhauer | Quiet | Medical devices | 2 | 0 |
| Carolyne LaSalaNot on the current fund | Quiet | None listed | 2 | 0 |
| Catherine Mohr | Quiet | None listed | 0 | 0 |
| John Friedman | Quiet | Biotech & pharma, Digital health | 8 | 0 |
| John OsborneNot on the current fund | Quiet | Sales & marketing tech | 6 | 0 |
| Lawrence Olanoff, PhD | Quiet | None listed | 0 | 0 |
| Lonny Yarmus, DO, PhD | Quiet | None listed | 0 | 0 |
| Maureen BoyceNot on the current fund | Quiet | None listed | 3 | 0 |
Activity is filed board seats in the last 24 months: 4+ Active, 2–3 Selective, 1 Slowing, none Quiet. A firm's tier totals its partners, so an active firm may be four partners with one seat each. It undercounts partners who invest without taking a board seat, and filings lag a closing by weeks, so Quiet means the paperwork is quiet, not the person.
| PROMEDIOR |
A shared board seat: a company where filings name a Good Growth Capital partner and a partner at the other firm, both with a clean identity match. Not a claim either firm led or co-led the round, only that both are named on the same board.